Related Experiment Videos
Pilot study on light dosimetry for endobronchial photodynamic therapy
J P Marijnissen1, P Baas, J F Beek
1Department of Clinical Physics, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Photochemistry and Photobiology
|July 1, 1993
Summary
Accurate light dosimetry is crucial for endobronchial photodynamic therapy (EB-PDT) of lung tumors. This study reveals significant variations in light delivery and potential hyperthermia, impacting treatment consistency.
Area of Science:
- Medical Physics
- Oncology
- Biophotonics
Background:
- Endobronchial photodynamic therapy (EB-PDT) is an emerging treatment for inoperable lung tumors.
- Photofrin is a common photosensitizer used in EB-PDT.
- Current limitations in light dosimetry hinder accurate interpretation of EB-PDT treatment outcomes.
Purpose of the Study:
- To investigate light dosimetry in endobronchial photodynamic therapy (EB-PDT).
- To evaluate the impact of different illumination fibers on light distribution.
- To assess potential hyperthermia risks during EB-PDT.
Main Methods:
- Exploratory light dosimetry experiments were conducted using plastic bronchus models.
- Microlens-tipped and cylindrical diffuser fibers were tested for illumination.
- In vivo experiments were performed in pig tracheas and rat tumor models to validate findings and assess temperature changes.
Main Results:
- Different illumination modalities resulted in varying light fluences within the tissue.
- Light fluence at 5 mm depth could vary by a factor of 3 based on cylindrical diffuser placement.
- In vivo temperature rises of 5-10°C were observed at specific depths and power outputs, indicating hyperthermia risk.
Conclusions:
- Light fluence and distribution in the bronchus are highly dependent on tissue properties and illumination technique.
- Inadequate dosimetry can lead to significant variations in patient treatment response.
- Further research into precise light dosimetry is essential for optimizing EB-PDT efficacy and safety.